Verona Pharma to Announce Q2 2024 Financial Results and Corporate Update

LONDON and RALEIGH, N.C., July 25, 2024 – Verona Pharma plc (Nasdaq: VRNA) has announced that it will release its financial results for the second quarter ending June 30, 2024, on Thursday, August 8, 2024. Following the announcement, the company will host a conference call for the investment community at 9:00 a.m. EDT / 2:00 p.m. BST to discuss these results and provide a corporate update.

Verona Pharma invites interested parties to participate in the conference call by dialing specific phone numbers: callers within the United States should dial +1-833-816-1396, while international callers can join by dialing +1-412-317-0489. In addition, a live webcast of the call will be accessible on the Events and Presentations section of the Investors page on the company's website. An audio replay of the webcast will be available for 90 days post-event.

About Verona Pharma:
Verona Pharma is a biopharmaceutical company that emphasizes the development and commercialization of new therapies for chronic respiratory diseases that currently lack adequate treatments. Their flagship product, OhtuvayreTM (ensifentrine), stands out as the first inhaled therapy designed for the maintenance treatment of COPD (Chronic Obstructive Pulmonary Disease). OhtuvayreTM uniquely combines bronchodilator effects with non-steroidal anti-inflammatory properties within a single molecule, offering a novel approach to COPD treatment.

Moreover, ensifentrine has shown potential for treating other respiratory ailments beyond COPD, including non-cystic fibrosis bronchiectasis, cystic fibrosis, asthma, and additional respiratory conditions. The company's focus on addressing significant unmet medical needs in respiratory care positions it as an innovative leader in the biopharmaceutical industry.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!